Form 4: Hims & Hers Health Chief Commercial Officer Michael Chi Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., exercised stock options and sold shares of Class A Common Stock between May 31, 2024, and June 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- Between May 31, 2024, and June 3, 2024, Chi exercised stock options to acquire Class A Common Stock at prices of $6.82 and $5.01.
- Concurrently, Chi sold shares of Class A Common Stock at prices ranging from approximately $18.92 to $21.00.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 1, 2024.
- The reported transactions resulted in adjustments to Chi's holdings of Class A Common Stock and derivative securities (stock options).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment about the company's prospects, but rather provides factual information about stock transactions by an executive.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Rule 10b5-1 trading plans are a common practice among corporate executives to sell shares in a pre-planned manner, avoiding accusations of insider trading.
- The vesting schedules of the options are typical for employee stock option plans, with a four-year vesting period and monthly vesting increments.
- Comparable companies such as Teladoc Health or GoodRx also have executives who utilize 10b5-1 plans and report similar Form 4 filings.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, as they reflect insider selling activity.
- However, the existence of a 10b5-1 plan suggests that these sales are pre-planned and not necessarily indicative of the executive's current outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 2022-02-24 | Date from which 1/48th of some stock options vest monthly. |
| 2022-09-10 | Date from which 1/48th of some stock options vest monthly. |
| 2024-03-01 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-05-20 | Date of acquisition of 967 shares under the Employee Stock Purchase Plan. |
| 2024-05-31 | Date of first reported transaction (stock option exercise and sale). |
| 2024-06-03 | Date of last reported transaction (stock option exercise and sale). |
| 2024-06-04 | Date of Form 4 filing. |
| 2032-02-24 | Expiration date of some stock options. |
| 2032-08-10 | Expiration date of some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.